Net profit of Genomic Valley Biotech declined 66.67% to Rs 0.02 crore in the quarter ended September 2023 as against Rs 0.06 crore during the previous quarter ended September 2022. Sales rose 250.00% to Rs 0.07 crore in the quarter ended September 2023 as against Rs 0.02 crore during the previous quarter ended September 2022.
| Particulars | Quarter Ended |
| | Sep. 2023 | Sep. 2022 | % Var. |
| Sales | 0.07 | 0.02 | 250 |
| OPM % | 28.57 | -150.00 | - |
| PBDT | 0.02 | -0.02 | LP |
| PBT | 0.02 | -0.03 | LP |
| NP | 0.02 | 0.06 | -67 |